For Which Cancer Types Should I Avoid Luobuma Supplement?

Highlights

Nutritional supplements and extracts like Luobuma have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Luobuma supplement and why should not take them?

Is it okay to take Luobuma extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.

A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.

To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.

Taking Luobuma extracts or nutritional supplements may benefit Primary Penile Squamous Cell Carcinoma patients on Cisplatin treatment over Yerba Santa nutritional supplements. But Luobuma supplements or Luobuma extracts offer less benefit if on Cisplatin treatment for Primary Vaginal Adenocarcinoma compared to Fennel. Similarly, taking nutritional supplements Luobuma may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene ERBB2 over Graviola. But avoid nutritional supplements Luobuma when at genetic risk of cancer due to mutation of gene.

The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Luobuma beneficial and should not be taken? Why should Luobuma be not taken? Who should not take Luobuma? What are side effects of Luobuma with Cisplatin chemotherapy? What are the benefits of Luobuma for cancer? Can Luobuma help fight cancer and so on.

Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.

Brief Overview

Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.

These are some example questions which nutrition planning should help answer for you. Should you take supplements Luobuma? Should you take it when at genetic risk of cancer for mutation of gene ERBB2? Should you take it when at genetic risk of cancer for mutation of gene? Should you take it when diagnosed with Primary Vaginal Adenocarcinoma? Should you take it when diagnosed with Primary Penile Squamous Cell Carcinoma? Should you take it when on Cisplatin treatment? Should you continue taking it if you change your treatment from Cisplatin to Cisplatin? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Luobuma extracts and nutritional supplements.

Cancer

Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Penile Squamous Cell Carcinoma or Primary Vaginal Adenocarcinoma, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Luobuma.

So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Luobuma extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene ERBB2 the same as due to mutation of gene? Are the implications of Primary Penile Squamous Cell Carcinoma the same as Primary Vaginal Adenocarcinoma? Is it one and the same if you are on treatment with Cisplatin or Cisplatin?

Luobuma – An Extract or Nutritional Supplement

Luobuma (Apocynum venetum), also known as sword-leaf dogbane, is a plant, native to  northern Asia and South East Europe. It is a great source of fiber and is considered to have medicinal properties. It is widely used in Chinese Traditional medicine. Following are some of the potential health benefits of Luobuma:

• May have antioxidant properties (Chong Li et al, Antioxidants (Basel)., 2019)
• May help reduce anxiety and depression (Wenyan Xie et al, J Ethnopharmacol., 2012)
• May help reduce blood pressure (Chie Tagawa et al, Yakugaku Zasshi., 2004)
• May act as a diuretic (Wenyan Xie et al, J Ethnopharmacol., 2012)

Luobuma supplements contain many active ingredients including Hyperoside at different concentration levels. The molecular pathways which are regulated by Luobuma include Cell Cycle, Oxidative Stress and Growth Factor Signaling. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Luobuma individually or in combination is an important decision to be made. When making decisions on the use of supplement Luobuma over other nutritional supplements – do consider all these factors.

Who Should not take Luobuma Supplements and Why?

There is no easy way to answer the question “For which cancers should I not chooseLuobuma nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Luobuma in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Luobuma should be avoided or not and why.

1. Will Luobuma Supplements benefit Primary Vaginal Adenocarcinoma patients undergoing Cisplatin treatment?

Primary Vaginal Adenocarcinoma is characterized and driven by specific genetic mutations like DNMT3A, CHEK2 and CREBBP leading to biochemical pathway changes in Oxidative Stress, Oncogenic Cancer Epigenetics, DNA Repair, Cell Cycle Checkpoints, G-protein-coupled Receptor Signaling and Immune Evasion Signaling. A cancer treatment like Cisplatin works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Luobuma supplement should not be taken for Primary Vaginal Adenocarcinoma along with treatment Cisplatin. Luobuma supplement impacts the biochemical pathway called Oxidative Stress which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any

2. Will Luobuma Supplements benefit Primary Penile Squamous Cell Carcinoma Patients undergoing Cisplatin Treatment?

Primary Penile Squamous Cell Carcinoma is characterized and driven by specific genetic mutations like ABRAXAS1, PIK3CB and NUP93 leading to biochemical pathway changes in Cell Cycle, Hematopoiesis and Inositol Phosphate Signaling. A cancer treatment like Cisplatin works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Luobuma supplements should be considered for Primary Penile Squamous Cell Carcinoma along with the treatment Cisplatin. Luobuma supplement impacts pathways/processes like Cell Cycle which either obstruct drivers of Primary Penile Squamous Cell Carcinoma and/or improve Cisplatin treatment effect.

3. What about Luobuma Supplements for Healthy Individuals with ERBB2 Mutation associated Genetic Risk?

ERBB2 is one of the genes available in panels for cancer risk testing. ERBB2 mutation causes biochemical pathways/processes like Growth Factor Signaling and PI3K-AKT-MTOR Signaling to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Luobuma supplements may be considered when the genetic panel identifies mutations in ERBB2 for Esophageal Adenocarcinoma. Luobuma impacts pathways/processes like Growth Factor Signaling and creates a canceling effect in those individuals with ERBB2 mutation.

* Other Factors are also included like BMI, Treatments, Lifestyle Habits

In Conclusion

It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Luobuma are chosen by you and can influence outcomes.

“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.

The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.

What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.

The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.

Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.

References

• Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells.
• cBioPortal for Cancer Genomics
• Hyperoside Induces Breast Cancer Cells Apoptosis via ROS-Mediated NF-κB Signaling Pathway.
• Inhibitors of the epidermal growth factor receptor in apple juice extract.
• The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
• cBioPortal for Cancer Genomics
• Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes.
• Cancer therapy shapes the fitness landscape of clonal hematopoiesis.